Inventor · disambiguated record
Nabil M. Ahmed
Also filed as: AHMED NABIL · AHMED NABIL M
3 granted patents·9 pending applications·28 citations·filing 2011–2022
66Inventor score
Top patents by PatentIndex Score
12 records- 0186US9493740B2Immunotherapy of cancer using genetically engineered GD2-specific T cellsBRENNER MALCOLM·Filed 2011·Granted Nov 15, 2016·25 cites·5 claims
- 0276US11219644B2Universal immune cells for cancer immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2016·Granted Jan 11, 2022·3 cites·9 claims
- 0354US2022313831A1Platform for enhanced targeted cell deliveryBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0452US2013280220A1Chimeric antigen receptor for bispecific activation and targeting of t lymphocytesAHMED NABIL·Filed 2013·Application pending·0 cites
- 0550US11376332B2Platform for enhanced targeted deliveryBAYLOR COLLEGE MEDICINE·Filed 2017·Granted Jul 5, 2022·0 cites·27 claims
- 0650US2025041341A1Polypeptides targeting cd105+ cancersBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0750US2025009798A1Engineered immune cells and methods for useBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0848US2022387493A1Method for producing cytotoxic effector memory t-cells for car t-cell treatment of cancerBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 0947US2016303230A1Chimeric antigen receptor for bispecific activation and targeting of t lymphocytesBAYLOR COLLEGE MEDICINE·Filed 2016·Application pending·0 cites
- 1044US2017027988A1Immunotherapy of cancer using genetically engineered gd2-specific t cellsBAYLOR COLLEGE MEDICINE·Filed 2016·Application pending·0 cites
- 1142US2016015750A1Vascular-targeted t-cell therapyBAYLOR COLLEGE MEDICINE·Filed 2014·Application pending·0 cites
- 1233US2018079824A1HER2/ErbB2 Chimeric Antigen ReceptorBAYLOR COLLEGE MEDICINE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nabil M. Ahmed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →